DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
McGovern AP, Hogg M, Shields BM. et al.
Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation.
BMJ Open Diab Res Care 2020;
8: e001238
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.